Chemotherapy of Hodgkin's disease

Bloomfield, 1982, Chemotherapy and combined modality therapy for Hodgkin's disease: a report on Cancer and Leukaemia Group studies, Cancer Treatment Reports, 66, 835 Bonadonna, 1985, Chemotherapy of malignant lymphomas, 12, 1 Bonadonna, 1975, Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine and imidazole carboxamide versus MOPP, Cancer, 36, 252, 10.1002/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO;2-7 Bonadonna, 1986, Alternating non cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease, Annals of Internal Medicine, 104, 739, 10.7326/0003-4819-104-6-739 Bubman, 1986, Treatment of Hodgkin's disease stages I and II with chemotherapy alone, Medical and Pediatric Oncology, 14, 208, 10.1002/mpo.2950140404 Canellos, 1972, Combination chemotherapy for advanced Hodgkin's disease in relapse following extensive radiotherapy, Clinical Pharmacology and Therapeutics, 13, 750, 10.1002/cpt1972135part1750 Canellos, 1983, Chemotherapy in the treatment of Hodgkin's disease, Seminars in Hematology, 20, 1 Canellos, 1987, Chemotherapy for Hodgkin's disease. Section II: alternative combinations and new approaches, 285 Canellos, 1988, MOPP vs ABVD vs MOPP alternating with ABVD in advanced Hodgkin's disease. A prospective randomised CALBG trial, 7, 230 Carbone, 1971, Report of the Committee on Hodgkin's Disease Staging Classification, Cancer Research, 31, 1860 Carde, 1983, A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy, Journal of Clinical Oncology, 1, 146, 10.1200/JCO.1983.1.2.146 Carde, 1988, NCI Monographs, 6, 303 Carde, 1988, Clinical stage I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors, Journal of Clinical Oncology, 6, 239, 10.1200/JCO.1988.6.2.239 Carella, 1988, High dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian Study Group report, Journal of Clinical Oncology, 6, 1411, 10.1200/JCO.1988.6.9.1411 Carmel, 1976, Mantle irradiation in Hodgkin's disease: an analysis of technique, tumor eradication and complications, Cancer, 37, 2813, 10.1002/1097-0142(197606)37:6<2813::AID-CNCR2820370637>3.0.CO;2-S Carter, 1973, Single agent therapy for Hodgkin's disease, Archives of Internal Medicine, 131, 377, 10.1001/archinte.1973.00320090067007 Chapman, 1979, Cytotoxic induced ovarian failure in Hodgkin's disease. II. Effects on sexual function, Journal of the American Medical Association, 242, 1882, 10.1001/jama.1979.03300170028021 Chapman, 1981, Male gonadal dysfunction in Hodgkin's disease. A prospective study, Journal of the American Medical Association, 245, 1323, 10.1001/jama.1981.03310380027020 Chilcote, 1976, Septicaemia and meningitis in children splenectomised for Hodgkin's disease, New England Journal of Medicine, 295, 798, 10.1056/NEJM197610072951502 Clamon, 1978, ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy, Cancer Treatment Reports, 62, 363 Craft, 1940, Results with roentgen ray therapy in Hodgkin's disease, 11, 391 Cramer, 1985, Hodgkin's disease in childhood and adolescence. Results of chemotherapy-radiotherapy in clinical stages IA-IIB, Journal of Clinical Oncology, 3, 1495, 10.1200/JCO.1985.3.11.1495 Crnkovich, 1987, Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Centre for Radiation Therapy, Journal of Clinical Oncology, 5, 1041, 10.1200/JCO.1987.5.7.1041 Dady, 1982, Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease, British Journal of Cancer, 45, 851, 10.1038/bjc.1982.137 DeVita, 1965, Intensive combination chemotherapy and x-irradiation in the treatment of Hodgkin's disease, 6, 15 DeVita, 1970, Combination chemotherapy in the treatment of advanced Hodgkin's disease, Annals of Internal Medicine, 73, L881, 10.7326/0003-4819-73-6-881 DeVita, 1980, Curability of advanced Hodgkin's disease with chemotherapy. Long term follow up of MOPP treated patients at the National Cancer Institute, Annals of Internal Medicine, 92, 587, 10.7326/0003-4819-92-5-587 Donaldson, 1988, Growth abnormalities associated with radiation in children with Hodgkin's disease, 7 Donaldson, 1990, Stage I–II pediatric Hodgkin's disease: long term follow up demonstrates equivalent survival rates following different management schemes, Journal of Clinical Oncology, 8, 1128, 10.1200/JCO.1990.8.7.1128 Dorreen, 1984, The management of stage II supradiaphragmatic Hodgkin's disease at St. Bartholomew's Hospital: a retrospective review of 114 previously untreated patients over 14 years, Cancer, 54, 2282, 10.1002/1097-0142(19841215)54:12<2882::AID-CNCR2820541212>3.0.CO;2-# Farah, 1989, Substaging of stage IV Hodgkin's disease, Hematology Oncology Clinics of North America, 3, 277, 10.1016/S0889-8588(18)30556-2 Finzi, 1913, Treatment of internal disease: lymphadenoma, 84 Fisher, 1979, Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse, Annals of Internal Medicine, 90, 761, 10.7326/0003-4819-90-5-761 Fuller, 1988, The adjuvant role of two cycles of MOPP and low dose lung irradiation in stage IA through IIB Hodgkin's disease: preliminary results, International Journal of Radiation Oncology, Biology, Physics, 14, 683, 10.1016/0360-3016(88)90090-9 Ganesan, 1990, Radiotherapy for stage I Hodgkin's disease—20 years' experience at St. Bartholomew's Hospital, British Journal of Cancer, 10.1038/bjc.1990.285 Gause, 1990, The prognostic value of Hodgkin-associated soluble CD30 antigen (CD30s) in the sera of patients with Hodgkin's disease, 9, 258 Gilbert, 1939, Radiotherapy in Hodgkin's disease (malignant granulomatosis): anatomic and clinical foundations; governing principles; results, American Journal of Roentgenology, 41, 198 Goldie, 1982, Rationale for the use of alternating non-cross resistant chemotherapy, Cancer Treatment Reports, 66, 439 Goodman, 1977, Stage IIA Hodgkin's disease: results of treatment with total nodal irradiation, 18, 348 Green, 1979, The incidence of post-splenectomy sepsis and herpes zoster in children and adolescents with Hodgkin's disease, Medical and Pediatric Oncology, 7, 285, 10.1002/mpo.2950070315 Gribben, 1989, Successful treatment of refractory Hodgkin's disease by high dose combination chemotherapy and autologous bone marrow transplantation, Blood, 73, 340, 10.1182/blood.V73.1.340.340 Hagemeister, 1982, Stage I and II Hodgkin's disease: involved field radiotherapy versus extended field radiotherapy versus involved field radio-therapy followed by six cycles of MOPP, Cancer Treatment Reports, 66, 789 Hagemeister, 1987, MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease, Journal of Clinical Oncology, 5, 556, 10.1200/JCO.1987.5.4.556 Hamilton Fairly, 1966, Chemotherapy of Hodgkin's disease with cyclophosphamide, vinblastine and procarbazine, British Medical Journal, ii, 75, 10.1136/bmj.2.5505.75 Hancock, 1986, Randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease, Radiotherapy and Oncology, 7, 215, 10.1016/S0167-8140(86)80032-9 Haybittle, 1985, Review of British National Lymphoma Investigation studies of Hodgkin's disease and development of prognostic index, Lancet, i, 967, 10.1016/S0140-6736(85)91736-2 Henkelman, 1988, Two cycles of MOPP and radiotherapy for stage IIIa and stage IIIb Hodgkin's disease, Journal of Clinical Oncology, 6, 1293, 10.1200/JCO.1988.6.8.1293 Henry-Amar, 1988, Quantitative risk of second cancer in patients in first complete remission from early stages of Hodgkin's disease, NCI Monographs, 6, 65 Hoppe, 1989, The management of bulky mediastinal Hodgkin's disease, Hematology/Oncology Clinics of North America, 3, 265, 10.1016/S0889-8588(18)30555-0 Hoppe, 1982, The management of stage I–II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience, Blood, 59, 455, 10.1182/blood.V59.3.455.455 Horning, 1981, Female reproductive potential after treatment for Hodgkin's disease, New England Journal of Medicine, 304, 1377, 10.1056/NEJM198106043042301 Horning, 1988, Vinblastine, bleomycin and methotrexate: an effective adjuvant in favourable Hodgkin's disease, Journal of Clinical Oncology, 6, 1822, 10.1200/JCO.1988.6.12.1822 Jacobs, 1984, Hodgkin's disease in children: a ten-year experience in South Africa, Cancer, 53, 210, 10.1002/1097-0142(19840115)53:2<210::AID-CNCR2820530204>3.0.CO;2-Z Jagannath, 1989, Prognostic factors for response and survival after high dose cyclophosphamide, carmustine and etoposide with autologous bone marrow transplantation for Hodgkin's disease, Journal of Clinical Oncology, 7, 179, 10.1200/JCO.1989.7.2.179 Kant, 1986, The pathological and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease, Journal of Clinical Oncology, 4, 284, 10.1200/JCO.1986.4.3.284 Kaplan, 1962, The radical radiotherapy of regionally localised Hodgkin's disease, Radiology, 78, 553, 10.1148/78.4.553 Kaplan, 1980 Karnofsky, 1966, Chemotherapy of Hodgkin's disease, Cancer, 19, 371, 10.1002/1097-0142(196603)19:3<371::AID-CNCR2820190310>3.0.CO;2-A Klimo, 1985, MOPP/ABV Hybrid Program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease, Journal of Clinical Oncology, 3, 1174, 10.1200/JCO.1985.3.9.1174 Klimo, 1988, An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid Program, Seminars in Hematology, 25, 34 Krikorian, 1978, Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, imidazole carboxamine (ABVD) after failure of MOPP therapy, Cancer, 41, 2107, 10.1002/1097-0142(197806)41:6<2107::AID-CNCR2820410606>3.0.CO;2-L Lacher, 1965, Combined vinblastine and chlorambucil therapy of Hodgkin's disease, Annals of Internal Medicine, 62, 468, 10.7326/0003-4819-62-3-468 Lee, 1981, The therapeutic utility of lung irradiation for Hodgkin's disease patients with large mediastinal masses, International Journal of Radiation Oncology, Biology, Physics, 7, 151, 10.1016/0360-3016(81)90430-2 Lee, 1987, Hodgkin's disease: a reassessment of prognostic factors following modification of radiotherapy, International Journal of Radiation Oncology, Biology, Physics, 13, 983, 10.1016/0360-3016(87)90035-6 Liew, 1983, Bulky mediastinal Hodgkin's disease: management and prognosis, Hematological Oncology, 2, 45, 10.1002/hon.2900020106 Lister, 1983, The treatment of stage IIIa Hodgkin's disease, Journal of Clinical Oncology, 1, 745, 10.1200/JCO.1983.1.12.745 Lister, 1989, Report of a Committee convened to discuss the evaluation and staging of patients with Hodgkin's disease; Cotswolds Meeting, 7, 1630 Longo, 1982, Chemotherapy for Hodgkin's disease: the remaining challenges, Cancer Treatment Reports, 66, 925 Longo, 1986, Twenty years of MOPP therapy for Hodgkin's disease, Journal of Clinical Oncology, 4, 1295, 10.1200/JCO.1986.4.9.1295 Longo, 1987, Randomised trial of MOPP chemotherapy vs subtotal nodal radiation therapy in patients with laparotomy-documented early stage Hodgkin's disease, 6, 206 Mauch, 1978, The significance of mediastinal involvement in early stage Hodgkin's disease, Cancer, 42, 1039, 10.1002/1097-0142(197809)42:3<1039::AID-CNCR2820420302>3.0.CO;2-R Mauch, 1983, An evaluation of long-term survival and treatment complications in children with Hodgkin's disease, Cancer, 51, 925, 10.1002/1097-0142(19830301)51:5<925::AID-CNCR2820510527>3.0.CO;2-O McElwain, 1977, Combination chemotherapy of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease, British Journal of Cancer, 36, 276, 10.1038/bjc.1977.187 Meadows, 1989, Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors, Medical and Pediatric Oncology, 17, 477, 10.1002/mpo.2950170525 Nicholson, 1970, Combination chemotherapy in generalised Hodgkin's disease, British Medical Journal, ii, 7, 10.1136/bmj.3.5713.7 Olver, 1988, Nitrogen mustard, vincristine, procarbazine and prednisolone for replase after radiation in Hodgkin's disease, Cancer, 62, 233, 10.1002/1097-0142(19880715)62:2<233::AID-CNCR2820620203>3.0.CO;2-L Olweny, 1978, Childhood Hodgkin's disease in Uganda: a ten year experience, Cancer, 42, 787, 10.1002/1097-0142(197808)42:2<787::AID-CNCR2820420251>3.0.CO;2-4 Oza, 1989, Patterns of survival in patients with advanced Hodgkin's disease treated in a single centre over 20 years, 8 Oza, 1990, Patterns of survival in Hodgkin's disease following relapse in patients treated at a single centre over a 21 year period, Annals of Oncology Pavlovsky, 1988, Randomised trial of chemotherapy versus chemotherapy plus radiotherapy for stage I–II Hodgkin's disease, Journal of the National Cancer Institute, 80, 1466, 10.1093/jnci/80.18.1466 Peters, 1950, A study of survival in Hodgkin's disease treated radiologically, American Journal of Roentgenology, 63, 299 Peters, 1958, A study of Hodgkin's disease treated by irradiation, American Journal of Roentgenology, 79, 114 Peterson, 1982, Effect of age on therapeutic response and survival in advanced Hodgkin's disease, Cancer Treatment Reports, 66, 889 Pfreundschuh, 1987, Cancer Treatment Reports, 71, 1203 Pfreundschuh, 1990, Detection of a soluble form of the CD30 antigen in sera of patients with lymphoma, adult T-cell leukaemia and infectious mononucleosis, International Journal of Cancer, 10.1002/ijc.2910450515 Phillips, 1986, Clinical studies of autologous bone marrow transplantation in Hodgkin's disease, Clinics in Haematology, 15, 151, 10.1016/S0308-2261(86)80009-1 Phillips, 1989, Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation, Blood, 73, 2086, 10.1182/blood.V73.8.2086.2086 Pillai, 1985, Prognostic factors for stage IV Hodgkin's disease treated with MOPP with or without bleomycin, Cancer, 55, 691, 10.1002/1097-0142(19850215)55:4<691::AID-CNCR2820550403>3.0.CO;2-Q Probert, 1973, Growth retardation in children after megavoltage irradiation of the spine, Cancer, 32, 634, 10.1002/1097-0142(197309)32:3<634::AID-CNCR2820320316>3.0.CO;2-A Prosnitz, 1978, Treatment of stage IIIA Hodgkin's disease: is radiotherapy alone adequate?, International Journal of Radiation Oncology, Biology, Physics, 4, 781, 10.1016/0360-3016(78)90036-6 Prosnitz, 1988, Combined modality therapy for advanced Hodgkin's disease: 15 year follow up data, Journal of Clinical Oncology, 6, 603, 10.1200/JCO.1988.6.4.603 Pui, 1989, High serum interleukin-2 receptor levels correlate with a poor prognosis in children with Hodgkin's disease, Leukemia, 3, 481 Richards, 1986, EVA treatment for recurrent or unresponsive Hodgkin's disease, Cancer Chemotherapy and Pharmacology, 18, 51, 10.1007/BF00253064 Richards, 1987, Prognostic factors in lymphoma, 10.1007/978-94-009-3291-3_20 Robinson, 1984, Chemotherapy and irradiation in childhood Hodgkin's disease, Archives of Disease in Childhood, 59, 1162, 10.1136/adc.59.12.1162 Rodgers, 1981, Reassessment of prognostic factors in stage IIIA and IIIB Hodgkin's disease treated with MOPP and radiotherapy, Cancer, 47, 2196, 10.1002/1097-0142(19810501)47:9<2196::AID-CNCR2820470915>3.0.CO;2-1 Rosenberg, 1985, The evolution and summary results for the Stanford randomised clinical trials of the management of Hodgkin's disease, 1962–1984, International Journal of Radiation Oncology, Biology, Physics, 11, 5, 10.1016/0360-3016(85)90357-8 Santoro, 1979, Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and decarbazine (ABVD), Cancer Chemotherapy and Pharmacology, 2, 101, 10.1007/BF00254081 Santoro, 1981, Alternating drug combinations in the treatment of advanced Hodgkin's disease, New England Journal of Medicine, 306, 770, 10.1056/NEJM198204013061303 Santoro, 1982, Salvage chemotherapy with ABVD in MOPP resistant Hodgkin's disease, Annals of Internal Medicine, 96, 139, 10.7326/0003-4819-96-2-139 Santoro, 1986, Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP, Cancer Treatment Reports, 7, 344 Santoro, 1987, Long term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy, Journal of Clinical Oncology, 5, 27, 10.1200/JCO.1987.5.1.27 Schellong, 1989, The German Co-operative Therapy Studies. An approach to minimise treatment modalities and invasive staging procedures, 277 Selby, 1987, Chemotherapy for Hodgkin's disease, 269 Selby, 1990, CHLVPP combination chemotherapy for Hodgkin's disease—long term results, British Journal of Cancer, 10.1038/bjc.1990.278 Skipper, 1967, Experimental evaluation of potential anticancer agents XXI: scheduling of arabinosylcytosine to take advantage of its S phase specificity against leukaemic cells, Cancer Chemotherapy Reports, 51, 125 Strauss, 1989, Treatment of advanced Hodgkin's disease, Hematology/Oncology Clinics of North America, 3, 287, 10.1016/S0889-8588(18)30557-4 Sutcliffe, 1987, Treatment of Hodgkin's disease, Baillière's Clinical Haematology, 1, 109, 10.1016/S0950-3536(87)80047-1 Sutcliffe, 1976, Intensive investigation in management of Hodgkin's disease, British Medical Journal, ii, 1343, 10.1136/bmj.2.6048.1343 Sutcliffe, 1978, MVPP chemotherapy regimen for advanced Hodgkin's disease, British Medical Journal, i, 679, 10.1136/bmj.1.6114.679 Sutcliffe, 1979, Adriamycin, bleomycin, vinblastine and imidazole carboxamide (ABVD) therapy for advanced Hodgkin's disease resistant to mustine, vinblastine, procarbazine and prednisolone (MVPP), Cancer Chemotherapy and Pharmacology, 2, 209, 10.1007/BF00258297 Sutcliffe, 1985, Prognostic groups for management of localised Hodgkin's disease, Journal of Clinical Oncology, 3, 393, 10.1200/JCO.1985.3.3.393 Tannir, 1983, Long-term follow up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease, Journal of Clinical Oncology, 1, 432, 10.1200/JCO.1983.1.7.432 Thar, 1979, Hodgkin's disease stages I and II. Relationship of recurrence to size of disease, radiation dose and number of sites involved, Cancer, 43, 1101, 10.1002/1097-0142(197903)43:3<1101::AID-CNCR2820430348>3.0.CO;2-3 Timothy, 1978, Radiotherapy in the treatment of Hodgkin's disease, British Medical Journal, i, 1246, 10.1136/bmj.1.6122.1246 Timothy, 1979, Hodgkin's disease: combination chemotherapy for relapse following radical radiotherapy, International Journal of Radiation Oncology, Biology, Physics, 5, 165, 10.1016/0360-3016(79)90715-6 Timothy, 1980, The management of stage IIIA Hodgkin's disease, International Journal of Radiation Oncology, Biology, Physics, 6, 135, 10.1016/0360-3016(80)90028-0 Tubiana, 1984, Prognostic significance of the number of involved areas in the early stages of Hodgkin's disease, Cancer, 54, 885, 10.1002/1097-0142(19840901)54:5<885::AID-CNCR2820540522>3.0.CO;2-B Tubiana, 1985, A multivariate analysis of prognostic factors in early stage Hodgkin's disease, International Journal of Radiation Oncology, Biology, Physics, 11, 23, 10.1016/0360-3016(85)90358-X Tucker, 1988, Risk of second cancers after treatment for Hodgkin's disease, New England Journal of Medicine, 318, 76, 10.1056/NEJM198801143180203 Wagstaff, 1988, Prognostic factors for survival in stage IIIB and IV Hodgkin's disease. A multivariate analysis comparing two specialist treatment centres, British Journal of Cancer, 58, 487, 10.1038/bjc.1988.246 Waxman, 1982, Gonadal function in Hodgkin's disease: long term follow up of chemotherapy, British Medical Journal, 285, 1612, 10.1136/bmj.285.6355.1612 Wedelin, 1984, Prognostic factors in Hodgkin's disease with special reference to age, Cancer, 53, 1202, 10.1002/1097-0142(19840301)53:5<1202::AID-CNCR2820530530>3.0.CO;2-L Whitehead, 1983, The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease, Cancer, 52, 988, 10.1002/1097-0142(19830915)52:6<988::AID-CNCR2820520610>3.0.CO;2-6 Wilimas, 1980, Long term results of treatment of children and adolescents with Hodgkin's disease, Cancer, 46, 2123, 10.1002/1097-0142(19801115)46:10<2123::AID-CNCR2820461002>3.0.CO;2-R Williams, 1989, The role of high dose therapy and autologous bone marrow re-infusion in the treatment of Hodgkin's disease, Hematology/Oncology Clinics of North America, 3, 319, 10.1016/S0889-8588(18)30559-8 Zittoun, 1985, Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease, Journal of Clinical Oncology, 3, 207, 10.1200/JCO.1985.3.2.207 Zulian, 1989, High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease, British Journal of Cancer, 59, 631, 10.1038/bjc.1989.128